Effect of sIL-13Rα2-Fc on the progression of rat tail intervertebral disc degeneration
Open Access
- 27 November 2019
- journal article
- research article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 14 (1) , 386
Abstract
Background: The incidence of degenerative disc disease caused by intervertebral disc injury is increasing annually, seriously affecting the quality of life of patients and increasing the disease burden on society. The mechanisms of intervertebral disc degeneration include changes in extracellular matrix (ECM) deposition and tissue fibrosis. sIL-13Rα2-Fc potently inhibits interleukin (IL)-13, as well as blocks related cell signaling pathways and inhibits fibrosis in certain tissues. However, it is unknown whether sIL-13Rα2-Fc inhibits fibrosis in injured intervertebral discs and slows the process of degeneration. We hypothesized that sIL-13Rα2-Fc delays the progression of intervertebral disc degeneration by inhibiting intervertebral disc fibrosis and improving ECM deposition. Methods: A rat tail intervertebral disc degeneration model was established. Pathological changes in rat intervertebral disc tissue were observed by hematoxylin and eosin staining and Masson staining. Glycosaminoglycan (GAG), chondroitin sulfate (CS), keratan sulfate (KS), and hyaluronic acid (HA) contents were quantitatively analyzed by enzyme-linked immunosorbent assay. Type I and type II collagen expression levels were analyzed by reverse transcription-PCR and western blotting. Results: Hematoxylin and eosin staining and Masson staining revealed annulus fibrosus rupture, disordered arrangement, decreased nucleus pulposus tissue, and decreased collagen fiber in the rat intervertebral disc tissue. Following treatment with sIL-13Rα2-Fc, pathological changes in the rat intervertebral disc were reduced. Rat intervertebral disc tissue showed decreased GAG, CS-KS, and (HA) contents, increased type I collagen levels, and decreased type II collagen levels in degenerated intervertebral discs. sIL-13Rα2-Fc intervention increased the contents of GAG, CS, KS, and HA; inhibited the expression of type I collagen; and promoted the expression of type II collagen. Conclusion: These results demonstrate that intervertebral disc degeneration is associated with tissue fibrosis. sIL-13Rα2-Fc can regulate type I and type II collagen expression levels by increasing GAG, CS, KS, and HA contents, thereby slowing the progression of intervertebral disc degeneration.Keywords
Funding Information
- China Postdoctoral Science Foundation (No. 2017M613342)
- Lanzhou Chengguan Science and Technology Bureau (No. 2017SHFZ0036)
- Gansu Natural Science Foundation (No.18JR3RA353)
- the first Hospital of Lanzhou University Foundation (No.ldyyyn2017-26)
This publication has 40 references indexed in Scilit:
- Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and DiseaseAnnual Review of Immunology, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Pathophysiology of Degenerative Disc DiseaseAsian Spine Journal, 2009
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- IL-13Rα2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in miceJournal of Clinical Investigation, 2007
- Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosisThe Journal of Pathology, 2003
- Changes with Age in Proteoglycan Synthesis in Cells Cultured In Vitro From the Inner and Outer Rabbit Annulus FibrosusSpine, 2000
- Cloning of the human IL‐13Rα1 chain and reconstitution with the IL‐4Rα of a functional IL‐4/IL‐13 receptor complexFEBS Letters, 1997
- The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.Journal of Clinical Investigation, 1996
- Collagen Synthesis and Types I, III, IV, and VI Collagens in an Animal Model of Disc DegenerationSpine, 1995